---
title: "Bicara Therapeutics Inc. (BCAX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/BCAX.US.md"
symbol: "BCAX.US"
name: "Bicara Therapeutics Inc."
industry: "生物技术"
---

# Bicara Therapeutics Inc. (BCAX.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [www.bicara.com](https://www.bicara.com) |

## Company Profile

Bicara Therapeutics Inc.是一家临床阶段的生物制药公司，专注于开发针对实体肿瘤的双功能疗法。其主要项目是 ficerafusp alfa，这是一种双功能抗体，结合了经过临床验证的表皮生长因子受体靶向单克隆抗体和一个与人类转化生长因子β结合的结构域，用于治疗实体肿瘤。该公司成立于 2018 年，总部位于马萨诸塞州波士顿

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -8.56 | 440/606 | - | - | - |
| PB | 2.58 | 196/606 | 2.27 | 1.56 | 1.32 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-23T05:00:00.000Z

Total Analysts: **13**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 7 | 54% |
| Overweight | 3 | 23% |
| Hold | 3 | 23% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 16.78 |
| Highest Target | 48.00 |
| Lowest Target | 11.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/BCAX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/BCAX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/BCAX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.